Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
24.72
-0.19 (-0.76%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Astrana Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,208 | 1,244 | 1,549 | 1,706 | 1,348 | 3,279 | Upgrade
|
| Market Cap Growth | -42.55% | -19.65% | -9.23% | 26.59% | -58.90% | 387.82% | Upgrade
|
| Enterprise Value | 1,857 | 1,647 | 1,477 | 1,687 | 1,396 | 3,242 | Upgrade
|
| Last Close Price | 24.72 | 24.81 | 31.53 | 38.30 | 29.59 | 73.48 | Upgrade
|
| PE Ratio | 53.95 | 55.34 | 35.89 | 28.10 | 29.84 | 47.57 | Upgrade
|
| Forward PE | 19.18 | 29.95 | 25.02 | 30.62 | 65.76 | 63.35 | Upgrade
|
| PS Ratio | 0.38 | 0.39 | 0.76 | 1.23 | 1.18 | 4.24 | Upgrade
|
| PB Ratio | 1.55 | 2.23 | 3.01 | 4.15 | 2.41 | 6.42 | Upgrade
|
| P/TBV Ratio | - | - | 8.84 | 6.47 | 6.85 | 27.57 | Upgrade
|
| P/FCF Ratio | 11.57 | 11.91 | 35.07 | 42.98 | 22.77 | 64.15 | Upgrade
|
| P/OCF Ratio | 10.55 | 10.86 | 29.67 | 25.01 | 16.41 | 46.62 | Upgrade
|
| PEG Ratio | 0.25 | 0.89 | 1.36 | 1.49 | 1.49 | 2.50 | Upgrade
|
| EV/Sales Ratio | 0.58 | 0.52 | 0.73 | 1.22 | 1.22 | 4.19 | Upgrade
|
| EV/EBITDA Ratio | 14.94 | 13.26 | 12.59 | 16.48 | 11.46 | 28.03 | Upgrade
|
| EV/EBIT Ratio | 23.65 | 20.98 | 16.53 | 19.93 | 13.39 | 33.03 | Upgrade
|
| EV/FCF Ratio | 17.77 | 15.77 | 33.44 | 42.49 | 23.59 | 63.44 | Upgrade
|
| Debt / Equity Ratio | 1.93 | 1.93 | 0.92 | 0.78 | 0.41 | 0.40 | Upgrade
|
| Debt / EBITDA Ratio | 7.69 | 7.69 | 3.64 | 2.94 | 1.79 | 1.67 | Upgrade
|
| Debt / FCF Ratio | 10.32 | 10.32 | 10.68 | 8.09 | 3.88 | 3.95 | Upgrade
|
| Net Debt / Equity Ratio | 1.16 | 1.16 | 0.35 | 0.06 | -0.11 | -0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.22 | 5.22 | 1.54 | 0.24 | -0.53 | -0.73 | Upgrade
|
| Net Debt / FCF Ratio | 6.21 | 6.21 | 4.10 | 0.63 | -1.08 | -1.65 | Upgrade
|
| Asset Turnover | 1.78 | 1.78 | 1.78 | 1.46 | 1.25 | 0.92 | Upgrade
|
| Quick Ratio | 1.35 | 1.35 | 1.68 | 2.03 | 2.76 | 3.33 | Upgrade
|
| Current Ratio | 1.40 | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 | Upgrade
|
| Return on Equity (ROE) | 4.49% | 4.49% | 10.80% | 11.94% | 8.56% | 9.64% | Upgrade
|
| Return on Assets (ROA) | 2.75% | 2.75% | 4.88% | 5.57% | 7.11% | 7.28% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.00% | 5.02% | 9.76% | 11.72% | 11.96% | 13.36% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.90% | 4.90% | 9.00% | 11.80% | 12.80% | 13.00% | Upgrade
|
| Earnings Yield | 1.86% | 1.81% | 2.79% | 3.56% | 3.35% | 2.10% | Upgrade
|
| FCF Yield | 8.65% | 8.40% | 2.85% | 2.33% | 4.39% | 1.56% | Upgrade
|
| Payout Ratio | - | 35.07% | - | 102.24% | 31.06% | 45.11% | Upgrade
|
| Buyback Yield / Dilution | -2.91% | -2.91% | -2.20% | -2.94% | -0.44% | -21.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.